BIBLIOGRAPHIC RECORD

Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Christopher S. Freet; Kirsten Shuler; Sarah Sharfstein Kawasaki; Eric Weintraub; Aaron David Greenblatt; Mat Kladney; Edward V. Nunes; Katrina L. Foster; Lan Kong; Nazia T. Raja-Khan; H. Harrington Cleveland; Patricia S. Grigson; Scott C. Bunce; Timothy R. Brick; Jennifer E. Nyland
Source of metadata
OpenAlex
Year recorded
2025

Public identifiers and source

Open the source record

Reference

Christopher S. Freet; Kirsten Shuler; Sarah Sharfstein Kawasaki; Eric Weintraub; Aaron David Greenblatt; Mat Kladney; Edward V. Nunes; Katrina L. Foster; Lan Kong; Nazia T. Raja-Khan; H. Harrington Cleveland; Patricia S. Grigson; Scott C. Bunce; Timothy R. Brick; Jennifer E. Nyland. (2025). Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol. https://openalex.org/W4415692559

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.